[{"address1": "19 Vestry Street", "city": "New York", "state": "NY", "zip": "10013", "country": "United States", "phone": "647 865 8622", "website": "https://brightmindsbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indications. Bright Minds Biosciences Inc. has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was founded in 2017 and is headquartered in New York, New York.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Ian  McDonald", "age": 36, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1988, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan E. S. K. Cheung B.Com., CA, CPA", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 83933, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jan Torleif Pedersen M.Sc., Ph.D.", "age": 59, "title": "Chief Science Officer & Director", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 170174, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Vasilkevich", "title": "COO & Senior Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emer  Leahy M.B.A., Ph.D.", "age": 57, "title": "Consultant", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen D. Collins M.D., Ph.D.", "age": 71, "title": "Chief Medical Officer", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 35.67, "open": 35.64, "dayLow": 34.5425, "dayHigh": 36.45, "regularMarketPreviousClose": 35.67, "regularMarketOpen": 35.64, "regularMarketDayLow": 34.5425, "regularMarketDayHigh": 36.45, "payoutRatio": 0.0, "beta": 0.665, "volume": 21176, "regularMarketVolume": 21176, "averageVolume": 69036, "averageVolume10days": 33600, "averageDailyVolume10Day": 33600, "bid": 34.81, "ask": 35.38, "bidSize": 1, "askSize": 1, "marketCap": 249400896, "fiftyTwoWeekLow": 0.93, "fiftyTwoWeekHigh": 79.02, "fiftyDayAverage": 36.7008, "twoHundredDayAverage": 21.11831, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 193545152, "forwardPE": -8.045978, "profitMargins": 0.0, "floatShares": 2598598, "sharesOutstanding": 7043990, "sharesShort": 107671, "sharesShortPriorMonth": 137699, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0153, "heldPercentInsiders": 0.22285, "heldPercentInstitutions": 0.72558, "shortRatio": 1.74, "shortPercentOfFloat": 0.0225, "impliedSharesOutstanding": 7125740, "bookValue": 8.274, "priceToBook": 4.2301183, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -1068069, "trailingEps": -0.14, "lastSplitFactor": "1:5", "lastSplitDate": 1689292800, "52WeekChange": 26.375288, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 35.0, "targetHighPrice": 91.95933, "targetLowPrice": 91.95933, "targetMeanPrice": 91.95933, "targetMedianPrice": 91.95933, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 57896664, "totalCashPerShare": 8.219, "totalDebt": 182733, "quickRatio": 125.592, "currentRatio": 126.151, "debtToEquity": 0.316, "returnOnAssets": -0.04926, "returnOnEquity": -0.03345, "freeCashflow": -1400343, "operatingCashflow": -2522493, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "DRUG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "REGULAR", "shortName": "Bright Minds Biosciences Inc.", "longName": "Bright Minds Biosciences Inc.", "corporateActions": [], "regularMarketTime": 1742412074, "exchange": "NCM", "messageBoardId": "finmb_691048918", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.878324, "regularMarketPrice": 35.0, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616419800000, "regularMarketChange": -0.66999817, "regularMarketDayRange": "34.5425 - 36.45", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 69036, "fiftyTwoWeekLowChange": 34.07, "fiftyTwoWeekLowChangePercent": 36.634407, "fiftyTwoWeekRange": "0.93 - 79.02", "fiftyTwoWeekHighChange": -44.019997, "fiftyTwoWeekHighChangePercent": -0.5570741, "fiftyTwoWeekChangePercent": 2637.5288, "epsTrailingTwelveMonths": -0.14, "epsCurrentYear": -1.9575, "priceEpsCurrentYear": -17.87995, "fiftyDayAverageChange": -1.7008018, "fiftyDayAverageChangePercent": -0.04634236, "twoHundredDayAverageChange": 13.881689, "twoHundredDayAverageChangePercent": 0.6573295, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-08", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "displayName": "Bright Minds Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]